Teladoc Health, Inc.
TDOC
$6.36
-$0.25-3.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -153.90% | 49.21% | -51.58% | 64.89% | -92.14% |
| Total Depreciation and Amortization | -6.52% | 20.25% | -1.34% | 4.79% | -13.92% |
| Total Amortization of Deferred Charges | -2.86% | -7.19% | -4.65% | 5.73% | 17.73% |
| Total Other Non-Cash Items | 54.79% | -70.68% | 107.03% | -73.42% | 85.75% |
| Change in Net Operating Assets | -968.89% | -82.92% | 78.46% | 133.23% | -476.86% |
| Cash from Operations | -89.15% | -11.61% | 8.57% | 474.36% | -81.47% |
| Capital Expenditure | 36.62% | -14.87% | -79.81% | 53.48% | 55.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -2,292.22% | 98.93% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.97% | -6.24% | 48.32% | -3.22% | -137.90% |
| Cash from Investing | -6.42% | 29.56% | 18.39% | 51.57% | -315.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -63.83% | 113.35% | -25.72% | -9.49% | -59.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -284,900.00% | 100.02% | -- | -- | -- |
| Cash from Financing | -321.83% | 130.73% | 99.35% | -71,612.74% | -62.63% |
| Foreign Exchange rate Adjustments | -389.29% | 195.06% | -107.22% | 183.03% | 141.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -155.34% | 17.60% | 109.08% | -389.27% | -292.79% |